Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
PROTACs are bifunctional molecules that allow the elimination of target proteins in the cells. Despite the advantages of this early field, the area of small molecules PROTACs presents some drawbacks, in particular, the long and tedious syntheses of the central linker. Secondly, the variety of those linkers is quite scarce, as poly-ether or alkyl chains are almost exclusively used. Thirdly, their length variation and effects on the activity of the PROTACs are rarely studied.
The goals of this project are to develop new synthetic routes allowing the easier synthesis of various linkers, develop new categories of linkers, and combine those advances to allow the rapid synthesis of a wide range of linkers that will constitute a toolbox for next generation bioconjugates, including but not limited to PROTACs . These goals will be achieved by the use of new technologies and chemical strategies. TO BE CONT’D
André Bernard Charette
NuChem Therapeutics
Life Sciences
Professional, scientific and technical services
Université de Montréal
Elevate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.